Haddadzadegan, Soheil
Saleh, Ahmad
Veider, Florina
Knoll, Patrick
Laffleur, Flavia
Kali, Gergely
Bernkop-Schnürch, Andreas https://orcid.org/0000-0003-4187-8277
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Accepted: 27 February 2025
First Online: 20 March 2025
Declarations
:
: We, the authors, give our full consent for the publication of our manuscript titled “Cyclodextrin-mediated enhancement of gastrointestinal drug delivery: Unveiling mucoadhesive and mucopenetrating synergy” in Drug Delivery and Translational Science, confirming that we have contributed to the work, reviewed the final version, and agreed to its submission. We affirm that the manuscript is original, free of conflicts, and complies with ethical and copyright requirements.
: The authors adhered to the ARRIVE guidelines, conducting all experiments in accordance with the Regulations of the Experimental Animal Administration and the Principles of Laboratory Animal Care, with approval from the Animal Ethical Committee in Vienna, Austria (Reference code: 2021–0.721.001). The studies complied with the EU Directive 2010/63 for animal protection. Sprague–Dawley rats, housed in a controlled environment with stable temperature, humidity, and unlimited food and water, were chosen for their established relevance in biomedical research due to their similarity to human biological systems. All procedures were designed to minimize suffering, with humane euthanasia performed using CO₂ inhalation in accordance with AVMA Guidelines, ensuring both animal welfare and experimental integrity.
: No potential conflict of interest was reported by the author(s).